Efficacy in major depressive disorder (MDD)

Cipralex treatment demonstrates superior efficacy to duloxetine in the treatment of acute major depressive disorder.

Cipralex (escitalopram) compares favourably to venlafaxine, both in moderate and severely ill depressed patients.

The more severe the depression is in the baseline the greater is the difference in efficacy between Cipralex and its comparators.

Cipralex is significantly more effective than paroxetine in the long-term treatment of severely depressed patients.

Cipralex demonstrates better efficacy, higher rates of response and remission and faster time to symptom relief.

Cipralex presents better efficacy and faster symptom relief